Skip to main content
Log in

Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com

  • Assisted Reproduction Technologies
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Purpose

To identify the leading treatment strategies for infertile women with PCOS on an international scale.

Methods

A retrospective evaluation using the results of a web-based survey, (IVF-Worldwide (www.IVF-worldwide.com), posted from 1 to 30 September 2010 was performed. Binomial confidence intervals for proportions were calculated by the modified Wald method with significance defined as P < 0.05 using a DataStar software package (DataStar, Waltham, MA, USA). Incomplete surveys were excluded from the analysis.

Results

The results from 262 centers in 68 nations were obtained. Clomiphene citrate was the clear first choice, 68 %, for PCOS treatment in the respondent group. Eighty-eight percent of respondents utilized ultrasound follicular monitoring when conducting ovulation induction with oral medications. A significant (p < 0.05) proportion of respondents (66 %) did use some BMI cutoff beyond which IVF treatment was not offered. The preferred IVF protocols for PCOS patients were gonadotropin releasing hormone (GnRH) antagonist, 46 %, and GnRH agonist, 51 %. There was heterogeneity of responses observed regarding the management of a patient at very high risk of OHSS.

Conclusions

While some advances, such as the use of GnRH antagonist regimen in IVF cycles, were relatively underutilized, the survey gives an unfiltered snapshot at the practice patterns of a large number of clinics. Results from this survey may be used by researchers and professional organizations to improve the clinical care of PCOS women suffering with infertility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. Gonadotropin-releasing hormone antagonsists for assisted reproductive technology. Cochrane Database Syst Rev. 2011;11(5), CD001750. doi:10.1002/14651858.CD001750.pub3.

    Google Scholar 

  2. Casper RF, Mitwally MF. Review: Aromatase inhibitors for ovulation induction. J Clin Endocrinol Metab. 2006;91(3):760–71.

    Article  PubMed  CAS  Google Scholar 

  3. Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction. Fertil Steril. 2012;98(6):1352–5.

    Article  PubMed  CAS  Google Scholar 

  4. Costello M, Misso M, Wong J, et al. The treatment of infertility in Polycystic ovarian syndrome: a brief update. Aus N Z J Obstet Gynaecol. 2012;52(4):400–3. doi:10.1111/j.1479-828X.2012.01448.

    Article  Google Scholar 

  5. Giannopoulos T, Sherriff E, Croucher C. Follicle tracking of women receiving clomiphene citrate for ovulation induction. J Obstet Gynaecol. 2005;25(2):169–71.

    Article  PubMed  CAS  Google Scholar 

  6. Homberg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:773–88.

    Article  Google Scholar 

  7. Lee VC, Ledger W. Aromatase inhibitors for ovulation induction and ovarian stimulation. Clin Endocrinol (Oxf). 2011;74(5):537–46. doi:10.1111/j.1365-2265.2011.04006.

    Article  CAS  Google Scholar 

  8. Magann EF, Doherty DA, Sandlin AT, Chauhan SP, Morrison JC. The effects of an increasing gradient of maternal obesity on pregnancy outcomes. Aus N Z J Obstet Gynaecol. 2013. doi:10.1111/ajo.12047.

    Google Scholar 

  9. Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 2007;13(5):433–44.

    Article  PubMed  CAS  Google Scholar 

  10. Nahid L, Sirous K. Comparison of the effects of letrozole and clomiphine citrate for ovulation induction in infertile women with polycystic ovary syndrome. Minerva Ginecol. 2012;64(3):253–8.

    PubMed  CAS  Google Scholar 

  11. Pettigrew R, Hamilton-Fairley D. Obesity and female reproductive function. Br Med Bull. 1997;53(2):341–58.

    Article  PubMed  CAS  Google Scholar 

  12. Pinborg A, Gaarsley C, Hougaard CO, Nyboe Andersen A, Andersen PK, Boivin J, et al. Influence of female bodyweight on IVF outcome: a longitudinal multicentre cohort study of 487 infertile couples. Reprod Biomed Online. 2011;23(4):490–9. doi:10.1016/j.rbmo.2011.06.010.

    Article  PubMed  CAS  Google Scholar 

  13. Shalom-Paz E, Marzal A, Wiser A, Almong B, Reinblatt S, Tulandi T, et al. Effects of different body mass indices on in vitro maturation in women with polycystic ovaries. Fertil Steril. 2011;96(2):336–9.

    Article  PubMed  Google Scholar 

  14. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive, and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41–50.

    Article  PubMed  CAS  Google Scholar 

  15. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril. 2006 Jun;85(6):1761–5.

  16. Wilkes S, Murdoch A. Ovulation induction with clomiphene: a primary care perspective. J Fam Plann Reprod Health Care. 2012;38(1):48–52. doi:10.1136/jfprhc-2011-0103.

    Article  PubMed  Google Scholar 

  17. Xiao J, Chen S, Zhang C, Chang S. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta-analysis. Gynecol Endocrinol. 2013;29(3):187–91. doi:10.3109/09513590.2012.736561.

    Article  PubMed  CAS  Google Scholar 

  18. Zander-Fox DL, Henshaw R, Hamilton H, Lane M. Does obesity really matter? The impact of BMI on embryo quality and pregnancy outcomes after IVF in women aged ≤38 years. Aus N Z J Obstet Gynaecol. 2012;52(3):270–6.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul R. Brezina.

Additional information

Capsule

This study describes the treatment patterns for PCOS via a survey of 262 centers in 68 nations.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brezina, P.R., Mensah, V., Balen, A. et al. Fertility management in the PCOS population: results of a web-based survey at IVF-worldwide.com. J Assist Reprod Genet 30, 1169–1174 (2013). https://doi.org/10.1007/s10815-013-0069-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-013-0069-z

Keywords

Navigation